SEC Form 4 Reporting Owner · CIK 0001068754
George J Morrow
Director at Neurocrine Biosciences Inc · Director at Align Technology Inc
Bought (12 mo)
—
Sold (12 mo)
−$4.49M
Form 4 Filings
21
Companies
2
Filing Activity
2026-11-03
first filed 2021-02-08
Trading record
Open-market buys
—
0 filings
Open-market sales
−$23M
5 filings
Sales under a 10b5-1 plan
60%
3 of 5 sale filings · 2 undisclosed
Companies
| Company | Role | Filings | Bought | Sold | Net | Holding after latest filing |
|---|---|---|---|---|---|---|
| NBIXNeurocrine Biosciences Insider trading | Director | 11 | — | 70,000 | −70,000 | 17,886 2026-11-03 |
| ALGNAlign Technology Insider trading | Director | 10 | — | 20,000 | −20,000 | 8,309 2026-05-22 |
Common-stock shares bought and sold on the open market, as reported on Form 4. The holding is what the latest filing at each company reported owning after its transactions.